NAS:GLPG (Belgium)  
Galapagos NV logo

Galapagos NV

$ 42.39 -1.16 (-2.66%) 10:08 PM EST
P/E:
At Loss
P/B:
1.06
Market Cap:
$ 2.83B
Enterprise V:
$ -1.45B
Volume:
171.25K
Avg Vol (2M):
180.01K
Also Trade In:
Volume:
171.25K
Market Cap $:
2.83B
PE Ratio:
At Loss
Avg Vol (2-Month):
180.01K
Enterprise Value $:
-1.45B
PB Ratio:
1.06
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.
Name Current Vs Industry Vs History
Cash-To-Debt 184.13
Equity-to-Asset 0.53
Debt-to-Equity 0.01
Debt-to-EBITDA 1.97
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.67
Distress
Grey
Safe
Beneish M-Score -2.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 8.79
9-Day RSI 17.87
14-Day RSI 23.95
6-1 Month Momentum % -19.43
12-1 Month Momentum % -6.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.23
Quick Ratio 8.18
Cash Ratio 8.04
Days Inventory 1139.71
Days Sales Outstanding 56.39
Days Payable 7532.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.4

Financials (Next Earnings Date:2022-11-03)

GLPG's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GLPG

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 559.835
EPS (TTM) ($) -1.41
Beta 0
Volatility % 33.84
14-Day RSI 23.95
14-Day ATR ($) 1.398013
20-Day SMA ($) 48.069
12-1 Month Momentum % -6.29
52-Week Range ($) 42.15 - 72.11
Shares Outstanding (Mil) 65.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Galapagos NV Filings

Document Form Filing Date
No Filing Data

Galapagos NV Analysis

Share your research

Headlines

See More
No news.